But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

Respiratory syncytial virus does present differently in folks of different ages,” says Kisha Davis, MD, a member of the board of directors of the American Academy of Family Physicians and the chief ...

Weekly COVID-19 case numbers reported by the Montana Department of Public Health and Human Services continue to drop.There ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Here’s what you need to know. While most people who contract RSV can recover at home, some are sick enough to be admitted to ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

Public health officials reiterated the importance of vaccines after seeing a rise in circulating levels of respiratory syncytial virus (RSV).

With changing recommendations and multiple seasonal viruses to contend with, here’s your simple guide to the 2024-2025 cold and flu season and when to call your doctor.

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

A WINTER ‘quadruple-demic’ of nasty viruses is set to strike the UK in just weeks. RSV, a potentially lethal lung infection, ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.